The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Tyro Payments (TYR) appoints Jonathan Davey as Chief Executive Officer (CEO), effective October 3
  • Mr Davey has been with the company since May 2021 and currently holds the role of CEO for Tyro’s health business
  • He will be paid a salary of $750,000 and will receive long and short term incentives on the achievement of certain milestones
  • To enable a smooth transition, outgoing CEO and Managing Director Robbie Cook has offered his services for the remainder of his notice period which concludes December 31
  • Shares are trading three per cent lower at $1.30 each at 11:40 am AEST

Tyro Payments (TYR) has appointed Jonathan Davey as Chief Executive Officer (CEO), effective October 3.

Mr Davey has been with the company since May 2021 and currently holds the role of CEO for Tyro’s health business.

He will be paid a salary of $750,000 and will receive long and short term incentives on the achievement of certain milestones.

Prior to this, Mr Davey spent 10 years at NAB in General Manager roles where he led NAB Labs, an innovation hub focused on rapid experimentation and commercialisation.

To enable a smooth transition, outgoing CEO and Managing Director Robbie Cook has offered his services for the duration of his notice period, which concludes December 31.

Chair David Thodey said the appointment follows an extensive search process.

“Jon is a seasoned technology executive who brings relevant experience from a 30-year career working in financial services, both within corporate and start-up environments,” he said.

Shares were trading three per cent lower at $1.30 each at 11:40 am AEST.

tyr by the numbers
More From The Market Online

KGL Resources jumps 25% on US$300M funding deal

KGL Resources has entered into a US$300 million PMPA to help fund construction and development of…
London

With osteo Phase 3 trial at 50% recruitment, Paradigm Bio inks partnership with University of London

Paradigm Biopharma (ASX:PAR) has this week hit two big items out the park: first of all, hitting 50% recruitment

Terra hits multiple intersections at Southwest SW6 prospect; assays now due in next ~12 weeks

Terra Metals has hit multiple intersections of massive sulphides in drilling at the Southwest SW6 prospect…
Easter bunny in a business suit analyzing stock charts, symbolizing market strategy

ASX closed for Easter long weekend. Enjoy your chocolates and the holiday break!

Yes, yes, I know you’re itching to do some serious Australian market trading today, but everyone — especially our much-loved HotCopper forum users